A Phase Ii Study Of Pre- And Post-Operative Gemcitabine And Erlotinib Plus Pancreaticoduodenectomy (Pd) For Patients With Resectable Pancreatic Ductal Adenocarcinoma (Pdac): Acosog Z5041 Trial (Alliance).Alice Chia-chi Wei,Fang-Shu Ou,Qian Shi,Eileen Mary O'Reilly,Jeffrey A. Meyerhardt,Robert A. Wolff,Hedy L. Kindler,Douglas B. Evans,Vikram Deshpande,Joseph Misdraji,Eric P. Tamm,Dushyant V. Sahani,Malcolm J. Moore,Elliot Newman,Nipun B. Merchant,Jordan Berlin,Laura W. Goff,Peter W.T. Pisters,Mitchell C. Posner, Acosog (Alliance)JOURNAL OF CLINICAL ONCOLOGY（2018）引用 0|浏览41暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
